EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Xenotransplantation Literature Update: July–December 2025

Kasra Shirini iD, Joseph M Ladowski, Niket Harsh, Raphael P H Meier iD

Xenotransplantation · 2026-03 · 33 (2)

DOI: 10.1111/xen.70123 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Xenotransplantation, online erschienen am 30.03.2026. Verfasst von Kasra Shirini und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA. Hauptthemen laut MEDLINE: Transplantation, Heterologous. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The second half of 2025 marked a significant transition for xenotransplantation, shifting further from experimental feasibility to early clinical translation. Prolonged physiologic support from genetically engineered porcine kidneys and livers in human recipients provided unprecedented insight into organ compatibility, rejection dynamics, and species‐specific physiology. Parallel advances in molecular profiling refined the understanding of innate and humoral immune injury, while innovations in donor‐pig engineering, immunomodulation, and biosafety frameworks strengthened translational readiness. Preclinical non‐human primate studies continued to inform clinical trial design, particularly regarding proteinuria, complement incompatibility, and novel xenoantigens. Alongside these scientific advances, growing attention to ethics, patient selection, and public trust highlighted the societal dimensions of clinical implementation. Collectively, these developments underscore the rapid maturation of xenotransplantation and define the scientific and regulatory foundations for ongoing first‐in‐human trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transplantation, HeterologousHumansAnimalsSwineGraft RejectionAnimals, Genetically ModifiedKidney Transplantation

Stichwörter der Autor:innen

clinical trialsgenetic modificationsimmunosuppressionkidney xenotransplantationliver xenotransplantationpig‐to‐human xenotransplantation

Autor:innen und Institutionen

  • Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Department of Surgery, Duke University School of Medicine, Durham, North Carolina, USA.
  • Department of Surgery, University of Maryland School of Medicine, Baltimore, Maryland, USA.

ORCID-Profile: Kasra Shirini, Raphael P H Meier

Zitieren

APA

Shirini, K., Ladowski, J. M., Harsh, N., & Meier, R. P. H. (2026). Xenotransplantation Literature Update: July–December 2025. Xenotransplantation, 33(2). https://doi.org/10.1111/xen.70123

Vancouver

Shirini K, Ladowski JM, Harsh N, Meier RPH. Xenotransplantation Literature Update: July–December 2025. Xenotransplantation. 2026;33(2). doi:10.1111/xen.70123

BibTeX
@article{Shirini2026,
  author = {Shirini, Kasra and Ladowski, Joseph M and Harsh, Niket and Meier, Raphael P H},
  title = {Xenotransplantation Literature Update: July–December 2025},
  journal = {Xenotransplantation},
  year = {2026},
  volume = {33},
  number = {2},
  doi = {10.1111/xen.70123}
}
Kostenlos starten →